The diabetic ocular environment facilitates the development of endogenous bacterial endophthalmitis

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 12, 2012, Pages 7426-7431

  Coburn, Phillip S ^a   Wiskur, Brandt J ^b   Christy, Elizabeth ^a   Callegan, Michelle C ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BACTERIAL ENDOPHTHALMITIS; BLOOD RETINA BARRIER; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DIABETES MELLITUS; ELECTRORETINOGRAPHY; ENDOPHTHALMITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; INCIDENCE; KLEBSIELLA PNEUMONIAE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CAPILLARY PERMEABILITY; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; FOLLOW-UP STUDIES; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICE; MICE, INBRED C57BL; RETINAL VESSELS;

EID: 84868330102     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-10661     Document Type: Article

References (55)

1. Jackson TL, Eykyn SJ, Graham EM, Stanford MR. Endogenous bacterial endophthalmitis: a 17-year prospective series and review of 267 reported cases. Surv Ophthalmol. 2003;48:403-423.
2. Greenwald MJ, Wohl LG, Sell CH. Metastatic bacterial endophthalmitis: a contemporary reappraisal. Surv Ophthalmol. 1986;31:81-101.
3. Shammas HF. Endogenous E. coli endophthalmitis. Surv Ophthalmol. 1977;21:429-435.
4. Okada AA, Johnson RP, Liles WC, D'Amico DJ, Baker AS. Endogenous bacterial endophthalmitis. Report of a ten-year retrospective study. Ophthalmology. 1994;101:832-838.
5. Romero CF, Rai MK, Lowder CY, Adal KA. Endogenous endophthalmitis: case report and brief review. Am Fam Physician. 1999;60:510-514.
6. Shrader SK, Band JD, Lauter CB, Murphy P. The clinical spectrum of endophthalmitis: incidence, predisposing factors, and features influencing outcome. J Infect Dis. 1990;162:115-120.
7. Fang CT, Chuang YP, Shun CT, Chang SC, Wang JT. A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications. J Exp Med. 2004;199:697-705.
8. Fung CP, Chang FY, Lee SC, et al. A global emerging disease of Klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis? Gut. 2002;50:420-424.
9. Chuang YP, Fang CT, Lai SY, Chang SC, Wang JT. Genetic determinants of capsular serotype K1 of Klebsiella pneumoniae causing primary pyogenic liver abscess. J Infect Dis. 2006;193:645-654.
10. Chang SC, Fang CT, Hsueh PR, Chen YC, Luh KT. Klebsiella pneumoniae isolates causing liver abscess in Taiwan. Diagn Microbiol Infect Dis. 2000;37:279-284.
11. Lederman ER, Crum NF. Pyogenic liver abscess with a focus on Klebsiella pneumoniae as a primary pathogen: an emerging disease with unique clinical characteristics. Am J Gastroenterol. 2005;100: 322-331.
12. Rahimian J, Wilson T, Oram V, Holzman RS. Pyogenic liver abscess: recent trends in etiology and mortality. Clin Infect Dis. 2004;39:1654-1659.
13. Fang FC, Sandler N, Libby SJ. Liver abscess caused by magA{thorn} Klebsiella pneumoniae in North America. J Clin Microbiol. 2005;43: 991-992.
14. Lederman ER, Crum NF. Klebsiella liver abscess: a coast-to-coast phenomenon. Clin Infect Dis. 2005;41:273.
15. Ko WC, Paterson DL, Sagnimeni AJ, et al. Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerg Infect Dis. 2002;8:160-166.
16. Ohmori S, Shiraki K, Ito K, et al. Septic endophthalmitis and meningitis associated with Klebsiella pneumoniae liver abscess. Hepatol Res. 2002;22:307-312.
17. Jardeleza MS, Chao-Chan C, Shalaby I, de la Cruz Z, Shen de F, Green WR. Clinicopathologic and ultrastructural study of endogenous Klebsiella pneumoniae endophthalmitis. Retina. 2005;25:657-662.
18. Scott IU, Matharoo N, Flynn HW Jr, Miller D. Endophthalmitis caused by Klebsiella species. Am J Ophthalmol. 2004;138:662-663.
19. Chen YJ, Kuo HK, Wu PC, et al. 10-year comparison of endogenous endophthalmitis outcomes: an east Asian experience with Klebsiella pneumoniae infection. Retina. 2004;24:383-390.
20. Giobbia M, Scotton PG, Carniato A, et al. Community-acquired Klebsiella pneumoniae bacteremia with meningitis and endophthalmitis in Italy. Int J Infect Dis. 2003;7:234-235.
21. Ayinala SR, Vulpe M, Azaz M, Cohen H, Donelson SS, Lee M. Pyogenic liver abscesses due to Klebsiella pneumoniae in a diabetic patient. J Miss State Med Assoc. 2001;42:67-70.
22. Saccente M. Klebsiella pneumoniae liver abscess, endophthalmitis, and meningitis in a man with newly recognized diabetes mellitus. Clin Infect Dis. 1999;29:1570-1571.
23. Liao HR, Lee HW, Leu HS, Lin BJ, Juang CJ. Endogenous Klebsiella pneumoniae endophthalmitis in diabetic patients. Can J Ophthalmol. 1992;27:143-147.
24. Rajala RV, Wiskur B, Tanito M, Callegan M, Rajala A. Diabetes reduces autophosphorylation of retinal insulin receptor and increases proteintyrosine phosphatase-1B activity. Invest Ophthalmol Vis Sci. 2009;50: 1033-1040.
25. Wiskur BJ, Hunt JJ, Callegan MC. Hypermucoviscosity as a virulence factor in experimental Klebsiella pneumoniae endophthalmitis. Invest Ophthalmol Vis Sci. 2008;49:4931-4938.
26. Ramadan RT, Ramirez R, Novosad BD, Callegan MC. Acute inflammation and loss of retinal architecture and function during experimental Bacillus endophthalmitis. Curr Eye Res. 2006;31:955-965.
27. Ramadan RT, Moyer AL, Callegan MC. A role for tumor necrosis factoralpha in experimental Bacillus cereus endophthalmitis pathogenesis. Invest Ophthalmol Vis Sci. 2008;49:4482-4489.
28. Hunt JJ, Wang JT, Callegan MC. Contribution of mucoviscosity associated gene A (magA) to virulence in experimental Klebsiella pneumoniae endophthalmitis. Invest Ophthalmol Vis Sci. 2011;52: 6860-6866.
29. Moyer AL, Ramadan RT, Novosad BD, Astley R, Callegan MC. Bacillus cereus-induced permeability of the blood-ocular barrier during experimental endophthalmitis. Invest Ophthalmol Vis Sci. 2009;50: 3783-3793.
30. Nielsen OL, Iburg T, Aalbaek B, et al. A pig model of acute Staphylococcus aureus induced pyemia. Acta Vet Scand. 2009;51:14.
31. Carter PB. Pathogenecity of Yersinia enterocolitica for mice. Infect Immun. 1975;11:164-170.
32. Wang JH, Liu YC, Lee SS, et al. Primary liver abscess due to Klebsiella pneumoniae in Taiwan. Clin Infect Dis. 1998;26:1434-1438.
33. Chen YJ, Kuo HK, Wu PC, et al. 10-year comparison of endogenous endophthalmitis outcomes: an east Asian experience with Klebsiella pneumoniae infection. Retina. 2004;24:383-390.
34. Pope JV, Teich DL, Clardy P, McGillicuddy DC. Klebsiella pneumoniae liver abscess: an emerging problem in North America. J Emerg Med. 2011;41:103-105.
35. Engler C, Krogsaa B, Lund-Andersen H. Blood-retina barrier permeability and its relation to the progression of diabetic retinopathy in type 1 diabetics. An 8-year follow-up study. Graefes Arch Clin Exp Ophthalmol. 1991;229:442-446.
36. Aiello LP, Gardner TW, King GL, et al. Diabetic retinopathy. Diabetes Care. 1998;21:143-156.
37. Fong DS, Aiello L, Gardner TW, et al. American Diabetes Association: diabetic retinopathy. Diabetes Care. 2003;26:226-229.
38. Neely KA, Gardner TW. Ocular neovascularization: clarifying complex interactions. Am J Pathol. 1998;153:665-670.
39. Qaum T, Xu Q, Joussen AM, et al. VEGF-initiated blood-retinal barrier breakdown in early diabetes. Invest Ophthalmol Vis Sci. 2001;42: 2408-2413.
40. Takeda M, Mori F, Yoshida A, et al. Constitutive nitric oxide synthase is associated with retinal vascular permeability in early diabetic rats. Diabetologia. 2001;44:1043-1050.
41. Asnaghi V, Gerhardinger C, Hoehn T, Adeboje A, Lorenzi M. A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes. 2003;52:506-511.
42. Martin PM, Roon P, Van Ells TK, Ganapathy V, Smith SB. Death of retinal neurons in streptozotocin induced diabetic mice. Invest Ophthalmol Vis Sci. 2004;45:3330-3336.
43. Jo DH, Kim JH, Kim JH. How to overcome retinal neuropathy: the fight against angiogenesis-related blindness. Arch Pharm Res. 2010;33: 1557-1565.
44. Schroder S, Palinski W, Schmid-Schonbein GW. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. Am J Pathol. 1991;139:81-100.
45. Miyamoto K, Hiroshiba N, Tsujikawa A, Ogura Y. In vivo demonstration of increased leukocyte entrapment in retinal microcirculation of diabetic rats. Invest Ophthalmol Vis Sci. 1998;39:2190-2194.
46. Miyamoto K, Khosrof S, Bursell SE, et al. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci U S A. 1999;96:10836-10841.
47. Funatsu H, Yamashita H, Sakata K, et al. Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema. Ophthalmology. 2005;112:806-816.
48. Giebel SJ, Menicucci G, McGuire PG, Das A. Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the bloodretinal barrier. Lab Invest. 2005;85:597-607.
49. Amrite AC, Ayalasomayajula SP, Cheruvu NP, Kompella UB. Single periocular injection of celecoxib-PLGA microparticles inhibits diabetesinduced elevations in retinal PGE2, VEGF, and vascular leakage. Invest Ophthalmol Vis Sci. 2006;47:1149-1160.
50. Losso JN, Truax RE, Richard G. trans-resveratrol inhibits hyperglycemiainduced inflammation and connexin downregulation in retinal pigment epithelial cells. J Agric Food Chem. 2010;58:8246-8252.
51. Dixon GL, Heyderman RS, Kotovicz K, et al. Endothelial adhesion molecule expression and its inhibition by recombinant bactericidal/permeability-increasing protein are influenced by the capsulation and lipooligosaccharide structure of Neisseria meningitidis. Infect Immun. 1999;67:5626-5633.
52. Simpson SQ, Singh R, Bice DE. Heat-killed pneumococci and pneumococcal capsular polysaccharides stimulate tumor necrosis factor-alpha production by murine macrophages. Am J Respir Cell Mol Biol. 1994;10:284-289.
53. Vallejo JG, Baker CJ, Edwards MS. Roles of the bacterial cell wall and capsule in induction of tumor necrosis factor alpha by type III group B streptococci. Infect Immun. 1996;64:5042-5046.
54. Lin J, Siu L, Fung C, et al. Impaired phagocytosis of capsular serotypes K1 or K2 Klebsiella pneumoniae in type 2 diabetes mellitus patients with poor glycemic control. J Clin Endocrinol Metab. 2006;91:3084-3087.
55. Park S, Rich J, Hanses F, Lee J. Defects in innate immunity predispose C57BL/6J-Leprdb/Leprdb mice to infection by Staphylococcus aureus. Infect Immun. 2009;77:1008-1014.